ARWR
ARROWHEAD PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$66.48
−1.86%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 48.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 20.17x
- Price / sales
- 14.03x
- Price / cash flow
- -159.01x
Enterprise value
- Enterprise value
- $8.7B
- EV / sales
- 12.92x
- EV / EBITDA
- -61.66x
- EV / EBIT
- -38.21x
- Market cap
- $9.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026